About a month ago, I reported on a study (known as the ENHANCE trial) which found that two cholesterol agents (simvastatin and ezetimibe) were no better than one (simvastatin) in terms of reducing the narrowing of arteries in the body. This blog post was based on data that had to be, it seems, forced [...]

More...